Medical Device News Magazine

SomaLogic Expands Leadership Team

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, today the company announced the recent appointments of Todd Johnson as Executive Vice President of Business Development and Strategy and Ruben Gutierrez, J.D. as General Counsel. In these roles, they will support SomaLogic’s efforts to expand its commercial growth and deliver on the power of proteomics.

“We are honored to have these highly accomplished industry leaders joining us at an exciting time in SomaLogic’s commercial expansion,” said SomaLogic President and Chief Operating Officer Melody Harris. “Todd and Ruben have the expertise and experience we need to move forward in the next evolution of our business.”

Todd Johnson will oversee SomaLogic’s portfolio of commercial partnerships. Prior to joining SomaLogic, he served as the Senior Vice President for Care Transformation at AVIA, the nation’s leading digital transformation partner for healthcare organizations. He also served as Chief Executive Officer at HealthLoop where he led the development of a digital platform that bridged communication between providers and patients, which was later deployed to more than 70 health systems and hospitals. When HealthLoop was acquired by GetWellNetwork, Mr. Johnson became the company’s Chief Strategy Officer where he realigned the company’s product portfolio to a more comprehensive ambulatory and at-home model.

Before HealthLoop, Todd was the founding CEO of Baltimore-based Salar, Inc., an acute care documentation solution. Working with the nation’s leading medical centers and physicians, he grew Salar to a successful acquisition in 2011 by Transcend Services, Inc. Transcend was, at the time, the nation’s second largest medical documentation company. Todd holds a Bachelor of Administration in computer science from Cornell University.

As General Counsel, Ruben Gutierrez will advise the SomaLogic executive team and ensure legal compliance across the organization. Prior to joining SomaLogic, he was Vice-President, Legal and Corporate Affairs for Natera, Inc., a genetic testing company based in San Carlos, California. Previously, Mr. Gutierrez served as the General Counsel of Human Longevity, Inc., a San Diego-based genomics research and health intelligence company, and served as Division Counsel, Biosciences at Thermo Fisher Scientific, Inc.

Prior to its acquisition by Thermo Fisher Scientific, Ruben held roles of increasing responsibility in the legal group of Life Technologies Corporation. Mr. Gutierrez received an LL.M. in Taxation from the New York University School of Law, a J.D. from the University of Southern California Gould School of Law and a B.A. from the University of California, Los Angeles.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”